Bayraktutan, Z. Et Al. 2022. Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury. JOURNAL OF INVESTIGATIVE SURGERY , vol.35, no.3 , 605-613.

Bayraktutan, Z., Dincer, B., Keskin, H., Kose, D., Bilen, A., Toktay, E., ... Sirin, B.(2022). Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury. JOURNAL OF INVESTIGATIVE SURGERY , vol.35, no.3, 605-613.

Bayraktutan, Zafer Et Al. "Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury," JOURNAL OF INVESTIGATIVE SURGERY , vol.35, no.3, 605-613, 2022

Bayraktutan, Zafer Et Al. "Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury." JOURNAL OF INVESTIGATIVE SURGERY , vol.35, no.3, pp.605-613, 2022

Bayraktutan, Z. Et Al. (2022) . "Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury." JOURNAL OF INVESTIGATIVE SURGERY , vol.35, no.3, pp.605-613.

@article{article, author={Zafer BAYRAKTUTAN Et Al. }, title={Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury}, journal={JOURNAL OF INVESTIGATIVE SURGERY}, year=2022, pages={605-613} }